Literature DB >> 21160990

Liver failure after an uncovered TIPS procedure associated with hepatic infarction.

Eric López-Méndez1, Daniel Zamora-Valdés, Mariana Díaz-Zamudio, Oscar F Fernández-Díaz, Lourdes Avila.   

Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) is a safe and effective procedure for the treatment of complications of liver cirrhosis, such as refractory ascites, hepatic hydrothorax and refractory variceal bleeding. The aim of this paper is to describe a rare case of liver failure after a TIPS procedure. A 38-year-old diabetic male with Child-Pugh C liver cirrhosis due to chronic hepatitis C infection who had developed refractory ascites was scheduled for a TIPS procedure. Within 24 h following TIPS placement, the patient developed distributive shock, jaundice, persistentgrade 3 hepatic encephalopathy, severe coagulopathy and acute renal failure. He was treated with lactulose enemas, broad-spectrum antibiotics and blood-derived products. Laboratory data revealed a 100-fold increase in aminotransferases and a non-enhanced computed tomography showed an irregular hypodense area in the right posterior segment of the liver. Despite being initially being in a stable condition, the patient developed progressive liver failure and died 2 mo later. Hepatic infarction is an uncommon phenomenon after a TIPS procedure; however, it can greatly complicate the course of a disease in a patient with an already compromised liver function.

Entities:  

Keywords:  Complications; Hepatic ischemia; Ischemic hepatitis; Liver infarction; Transjugular intrahepatic portosystemic shunt

Year:  2010        PMID: 21160990      PMCID: PMC2998963          DOI: 10.4254/wjh.v2.i4.167

Source DB:  PubMed          Journal:  World J Hepatol


  19 in total

1.  Liver infarction following TIPS with a PTFE-covered stent: is the covering the cause?

Authors:  Jeanne M LaBerge; Robert K Kerlan
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

2.  Hepatic infarction: unusual complication of a transjugular intrahepatic portosystemic shunt.

Authors:  R Sawhney; S D Wall; J Yee; I Hayward
Journal:  J Vasc Interv Radiol       Date:  1997 Jan-Feb       Impact factor: 3.464

3.  Vascular complication of a transjugular intrahepatic portacaval stent.

Authors:  J M Villemaire; M P Dufresne; G Lebouthillier; D Picard; J Morais; R Chartrand; M Picard
Journal:  Clin Nucl Med       Date:  1993-11       Impact factor: 7.794

4.  Perinodular arteriolar plexus in liver cirrhosis. Scanning electron microscopy of microvascular casts.

Authors:  T Yamamoto; T Kobayashi; M J Phillips
Journal:  Liver       Date:  1984-02

Review 5.  Fatal liver infarction after transjugular intrahepatic portosystemic shunt procedure.

Authors:  H Mayan; R Kantor; U Rimon; N Golubev; Z Heyman; E Goshen; B Shalmon; P Weiss
Journal:  Liver       Date:  2001-10

6.  Prevention of hepatic infarction as acute-phase complication of TIPS by temporary balloon occlusion in a patient with primary myelofibrosis.

Authors:  Satoshi Kobayashi; Osamu Matsui; Jun Yoshikawa; Toshifumi Gabata; Yasuhiro Kawamori; Junichiro Sanada; Noboru Terayama; Masumi Kadoya
Journal:  Radiat Med       Date:  2004 Nov-Dec

7.  Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.

Authors:  A Baron; V Gulberg; G Sauter; T Waggershauser; M Reiser; A L Gerbes
Journal:  Hepatogastroenterology       Date:  1998 Nov-Dec

8.  Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study.

Authors:  Christophe Bureau; Juan Carlos Garcia Pagan; Gilles Pomier Layrargues; Sophie Metivier; Pablo Bellot; Pierre Perreault; Philippe Otal; Juan-G Abraldes; Jean Marie Peron; Hervé Rousseau; Jaume Bosch; Jean Pierre Vinel
Journal:  Liver Int       Date:  2007-08       Impact factor: 5.828

9.  Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.

Authors:  Oliviero Riggio; Stefania Angeloni; Filippo Maria Salvatori; Adriano De Santis; Federica Cerini; Alessio Farcomeni; Adolfo Francesco Attili; Manuela Merli
Journal:  Am J Gastroenterol       Date:  2008-09-04       Impact factor: 10.864

10.  Functional hepatic flow in patients with liver cirrhosis.

Authors:  Zheng Pan; Xing-Jiang Wu; Jie-Shou Li; Fang-Nan Liu; Wei-Su Li; Jian-Ming Han
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

View more
  4 in total

Review 1.  Transjugular intrahepatic portosystemic shunt complications: prevention and management.

Authors:  Paul V Suhocki; Matthew P Lungren; Baljendra Kapoor; Charles Y Kim
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

2.  Transjugular intrahepatic portosystemic shunt does not independently increase risk of death in high model for end stage liver disease patients.

Authors:  Erin K Spengler; Lawrence G Hunsicker; Sanam Zarei; M Bridget Zimmerman; Michael D Voigt
Journal:  Hepatol Commun       Date:  2017-06-07

3.  Acute liver failure and infarction complicating TIPS placement.

Authors:  Guo-Ping Liu; Mei-Ying Zhang; Rui Xu; Cheng-Jian Sun
Journal:  Radiol Case Rep       Date:  2019-05-10

Review 4.  Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.

Authors:  Sasidharan Rajesh; Tom George; Cyriac Abby Philips; Rizwan Ahamed; Sandeep Kumbar; Narain Mohan; Meera Mohanan; Philip Augustine
Journal:  World J Gastroenterol       Date:  2020-10-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.